Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Aspira Women's Health's revenue for the twelve months ending Jun 30, 2026 was $170.00K. For fiscal 2025 it was $343.00K, up 8475.0% from the year before. Over ten years it grew -16.9% a year on average. The highest annual figure on record is $87.00M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $343.00K | +8475.0% |
| FY2024 | Dec 31, 2024 | $4.00K | -100.0% |
| FY2023 | Dec 31, 2023 | $87.00M | +963.0% |
| FY2022 | Dec 31, 2022 | $8.18M | +20.1% |
| FY2021 | Dec 31, 2021 | $6.81M | +46.5% |
| FY2020 | Dec 31, 2020 | $4.65M | +2.5% |
| FY2019 | Dec 31, 2019 | $4.54M | +48.6% |
| FY2018 | Dec 31, 2018 | $3.05M | -2.2% |
| FY2017 | Dec 31, 2017 | $3.12M | +18.1% |
| FY2016 | Dec 31, 2016 | $2.64M | +21.4% |
| FY2015 | Dec 31, 2015 | $2.18M | -13.6% |
| FY2014 | Dec 31, 2014 | $2.52M | -1.8% |
| FY2013 | Dec 31, 2013 | $2.57M | +22.5% |
| FY2012 | Dec 31, 2012 | $2.09M | +8.9% |
| FY2011 | Dec 31, 2011 | $1.92M | +63.7% |
| FY2010 | Dec 31, 2010 | $1.18M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.00K | -89.9% |
| Q1 FY2026 | Mar 31, 2026 | $32.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $32.00K | -98.6% |
| Q3 FY2025 | Sep 30, 2025 | $89.00K | -96.3% |
| Q2 FY2025 | Jun 30, 2025 | $169.00K | -92.2% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.26M | +1.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.42M | -2.7% |
| Q1 FY2024 | Mar 31, 2024 | $2.15M | -7.0% |
| Q4 FY2023 | Dec 31, 2023 | $79.98M | +3614.6% |
| Q3 FY2023 | Sep 30, 2023 | $2.22M | +7.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.49M | +20.6% |
| Q1 FY2023 | Mar 31, 2023 | $2.32M | +22.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.15M | +16.3% |
| Q3 FY2022 | Sep 30, 2022 | $2.07M | +24.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.07M | +14.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.89M | +26.5% |
| Q4 FY2021 | Dec 31, 2021 | $1.85M | +28.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.67M | +34.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.80M | +141.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.50M | +22.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.45M | +10.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.24M | -3.6% |
| Q2 FY2020 | Jun 30, 2020 | $746.00K | -34.7% |
| Q1 FY2020 | Mar 31, 2020 | $1.22M | +51.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.31M | +41.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.29M | +66.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.14M | +61.3% |
| Q1 FY2019 | Mar 31, 2019 | $803.00K | +23.7% |
| Q4 FY2018 | Dec 31, 2018 | $922.00K | +15.5% |
| Q3 FY2018 | Sep 30, 2018 | $774.00K | +10.7% |
| Q2 FY2018 | Jun 30, 2018 | $708.00K | -21.2% |
| Q1 FY2018 | Mar 31, 2018 | $649.00K | -10.6% |
| Q4 FY2017 | Dec 31, 2017 | $798.00K | -0.9% |
| Q3 FY2017 | Sep 30, 2017 | $699.00K | +12.2% |
| Q2 FY2017 | Jun 30, 2017 | $898.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $726.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $805.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $623.00K | – |
See a number that looks wrong?